Understanding how Merkel cell skin cancer develops
Unraveling the regulatory circuits that drive Merkel cell carcinoma
This research explores how a specific virus causes Merkel cell carcinoma, a rare and aggressive skin cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-11136473 on NIH RePORTER |
What this research studies
Merkel cell carcinoma is a serious skin cancer that can be caused by the Merkel cell polyomavirus. We are looking at how two specific viral genes, called ST and LT antigens, change normal cells to become cancerous and spread. By studying these changes in a controlled setting, we can observe the exact steps that lead to tumor formation. This approach helps us understand the disease's progression in a way that is not possible by just looking at existing tumors.
Who could benefit from this research
Good fit: This foundational research is relevant for patients diagnosed with Merkel cell carcinoma, particularly those whose cancer is linked to the Merkel cell polyomavirus.
Not a fit: Patients with cancers unrelated to Merkel cell carcinoma or its viral cause may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to prevent or treat Merkel cell carcinoma by targeting the specific mechanisms that drive its development.
How similar studies have performed: While the viral etiology of Merkel cell carcinoma offers a unique opportunity, this specific approach to systematically quantify regulatory changes during carcinogenesis is novel.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Padi, Megha — University of Arizona
- Study coordinator: Padi, Megha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.